Biogen and Eisai file for Japan approval of Aducanumab, page-2

  1. 956 Posts.
    lightbulb Created with Sketch. 313
    Just to put the size of the Japan market in to context as of last year they had @38 million people over the age +65, by contrast the US had a population of @50 million +65 years. This is a very meaningful market for Aducanumab and by extension Cogstate.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.79
Change
-0.005(0.28%)
Mkt cap ! $303.9M
Open High Low Value Volume
$1.80 $1.82 $1.78 $65.60K 36.42K

Buyers (Bids)

No. Vol. Price($)
3 1397 $1.79
 

Sellers (Offers)

Price($) Vol. No.
$1.80 1658 2
View Market Depth
Last trade - 13.18pm 23/07/2025 (20 minute delay) ?
CGS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.